Global stock

NYSEUSD

Nomura Holdings (ADR)

NMR

AI analysis and articles are in Czech.

§ Financial healthLong-term stability

63/ 100

Overall score·NMR

Current price

8.99USD

26/10/2026

P/E, P/B

Valuation

Strong

Rates whether the stock is cheap or expensive relative to its history and sector. A score above 60 suggests the stock trades below its estimated intrinsic value.

Tracks:P/E · P/B · FCF yield · sector

P/E 11,3 a P/B 1,15 působí vzhledem k finančnímu sektoru relativně umírněně a PEG 0,81 podporuje příznivější pohled na ocenění; forward P/E 17,4 je však vyšší než současné P/E. Růst EPS i tržeb je silný, zatímco velmi vysoký poměr dluhu k vlastnímu kapitálu výrazně oslabuje stabilitu; cena se drží pod 50denním, ale nad 200denním průměrem.

§ Outlook vs S&P 500Next 12 months

Probably yes

Estimated chance of beating the index: about 58%

8 of 8 inputs

NoProbably notSameProbably yesYes

A model estimate from current values. The result may change with new data; it is not a price target or an investment recommendation.

§ Context and events

Management

Skupinu vede Kentaro Okuda, President a Group CEO. Hiroyuki Moriuchi je CFO a Sotaro Kato odpovídá za řízení rizik. Strategie stojí na propojení domácích aktivit v Japonsku s mezinárodním investičním bankovnictvím a správou aktiv; její výsledky jsou citlivé na tržní podmínky a disciplínu při řízení rizik.

Articles about Nomura Holdings (ADR), in Czech (1)

Market chatter: JPMorgan a Nomura vybírány pro prodej akcií Waaree Energies za 700 milionů dolarů

Podle zpráv z 29. května 2026 se JPMorgan a Nomura objevily jako hlavní banky vybrané k zajištění prodeje akcií indické společnosti Waaree Energies v hodnotě 700 milionů dolarů. Tento krok je součástí širšího plánu firmy zvýšit kapitál prostřednictvím veřejné nabídky akcií.

30 May 2026· 3 min

§ Upcoming results

28 October 2026

Tomorrow

Earnings

Earnings = quarterly financial results (revenue and profit). Companies publish them every three months and the share price often reacts strongly.

§ Frequently asked questions

What is Nomura Holdings (ADR) (NMR)?

Nomura Holdings (ADR) (NMR) is a global stock traded on NYSE. Sector: Financial services. We track it daily — scoring news sentiment, the short-term outlook and long-term stability on a 0–100 scale.

What is the Nomura Holdings (ADR) price today?

As of 26 October 2026, Nomura Holdings (ADR) trades at about 8.99 USD per unit. We update the price daily from public market data. Intraday moves can differ significantly — always check the final price with your broker.

How to buy Nomura Holdings (ADR)?

Through regulated online brokers such as Degiro, XTB, Trading 212 or Interactive Brokers. Shares trade in USD or EUR — most brokers convert your currency automatically. FinSignal does not operate any of these platforms and charges no commission — the overview is only a signpost.

Does Nomura Holdings (ADR) pay a dividend?

Nomura Holdings (ADR) either pays no dividend at the moment or we have no reliable data on it. Many growth companies prefer reinvesting profit to paying dividends — check the current policy in the company's investor relations materials.

Is Nomura Holdings (ADR) a good investment in 2026?

Our AI signal currently rates Nomura Holdings (ADR) as slightly negative (score 37/100). Financial health comes out at 63/100, so beyond short-term news it is worth watching the valuation, growth, profitability and stability of the company. FinSignal is not an investment adviser licensed under Czech Act No. 256/2004 Coll. — signals are analytical input, not a recommendation to buy or sell. You make every decision at your own risk.

§ More global stocks

Microsoft Corporation

§ How to buy Nomura Holdings (ADR)

You can buy shares through regulated online brokers available in the EU. They differ mainly in fees, app quality and which markets they cover.

Degiro
Dutch broker with low fees for passive investors. No account fee, trading in EUR and USD.
XTB
Polish broker with zero commission on stocks and ETFs up to EUR 100,000 a month. Own xStation platform.
Trading 212
Zero-commission broker with fractional shares from EUR 1 and automated investing (Pies). Suits beginners and regular investing.
Interactive Brokers
US broker for advanced investors. The widest choice of markets, low costs at larger volumes, a professional platform with a steeper learning curve.

FinSignal operates none of these platforms. We charge no commission on purchases.

Important: Signals are an analytical tool, not investment advice within the meaning of Czech Act No. 256/2004 Coll. Past performance does not guarantee future results. You make all decisions at your own risk.

§ Current signalShort-term mood

/ 100

● Slightly negative

Earnings tomorrow

On 28 October 2026 the company publishes its quarterly results. This period tends to bring large price moves.

News summary

Older news

Signal 23/10, 21:02

Nomura má 28. října zveřejnit výsledky za 2. čtvrtletí; očekává se meziroční pokles zisku. Slabší sazební obchodování může výsledek zatížit, silné akciové obchodování by dopad zmírnilo.

Cena za 7 i 30 dní klesá, trend je sestupný a RSI 20 značí přeprodanost; slabé momentum zvyšuje krátkodobý tlak, ale může následovat technické oživení. Dlouhodobější obraz zůstává nejednoznačný.

Risks: Výrazně lepší výsledky či výhled mohou pokles obrátit; další oslabení obchodních příjmů by naopak zhoršilo krátkodobý výhled.

More about the signal

Risks: Výrazně lepší výsledky či výhled mohou pokles obrátit; další oslabení obchodních příjmů by naopak zhoršilo krátkodobý výhled.

Signal history· 2

09/1011:3153 · Neutral
Zpráva dne 2. října 2026 uvádí, že akcie Nomury vytvořila technický formaci „hammer“, která může naznačovat obrat po poklesu, sama o sobě však jeho potvrzení nedokládá. Trvalejší dopad by vyžadoval následné potvrzení ceny a trendu.
06/1002:0242 · Slightly negative
Článek porovnává Nomuru (NMR) s TW z hlediska hodnotové investice, ale samotný titulek neuvádí, která akcie vychází lépe. Krátkodobý cenový tlak podporuje pokles Nomury o 8,19 % za 30 dní a klesající trend.

The full 90-day signal history is part of Premium.

Ask the AI

DCF valuation

A DCF model is not suitable for this asset class.

§ Valuation check

Is the price reasonable?

Six quick tests: price against fair value, the last year, similar companies and analyst estimates. They are calculated from the numbers, not from AI estimates. This is not a recommendation.

Data 16 of 18

Valuation score

3/ 6

3/6 tests available

1. Below DCF fair value

The complete DCF range or the current price is missing.

2. Well below DCF value

The complete DCF range or the current price is missing.

3. Price vs. the last year

46% above the 1-year low (7.40 USD to 10.86 USD), based on stored daily prices.

4. P/E vs. similar companies

P/E 11.3 vs. median 16.6 (65 companies).

5. P/E relative to growth

PEG 0.8; a lower value means cheaper growth.

6. Analyst price target

A price target exists, but coverage is too low to count in the score.

Price and fair value

no complete range

The DCF check appears once both the price and the model range are available.

Price vs analyst target

Current price

8.99 USD

Low 11.22 USDHigh 11.22 USD

Current priceAverage: 11.22 USD

DCF gap

no complete range

The DCF check appears once both the price and the model range are available.

Analyst target

+24.8%

Average target 11.22 USD vs. price 8.99 USD.

Analyst consensus

Target range

11.22 USD - 11.22 USD

Coverage

1 analyst

Analyst consensus

Changes 180 d

+0 / -0

EPS next year

-0.6%

Revenue next year

0.2%

Valuation multiples

11.3

17.4

1.2

0.8

52-week range46% above the low

7.40 USD10.86 USD

42.0%

31.0%

17.3%

11.2%

Price vs 50D-10.2%

Price vs 200D0.7%

Metrics explained+

Price and fair value

DCF range: A model estimate of fair value from future free cash flow. A price above the range means the market pays a premium over the model; a price below it may signal a more conservative market valuation or an overly optimistic model.
Analyst target: The average and range of the analyst price targets we track. It is the market consensus, not a FinSignal recommendation, and it can lag fast price moves.
52-week range: Shows where the current price sits between the low and high of the last year. A value near the high often signals strong momentum, but on its own says nothing about whether the stock is expensive.
Price vs 50D / 200D: Compares the price with its short- and long-term moving averages. A positive value means the price is above the trend; a negative one below it.

Multiples

P/E: Price relative to current earnings. A lower P/E can mean cheaper, but it can also point to a weak outlook or risk.
Forward P/E: Price relative to next year's expected earnings. For growing companies it is often more useful than the historical P/E because it reflects estimates of future earnings.
P/B: Price relative to the book value of equity. It makes more sense for banks, insurers and capital-intensive companies than for software or brands.
P/S: Price relative to revenue. It helps with companies that have low or negative earnings; a high P/S means the market expects strong growth or future margins.
EV/EBITDA: The value of the whole company, including debt, relative to operating profit before depreciation. Useful for comparing companies with different leverage.
PEG: P/E adjusted for earnings growth. A value around 1 may suggest the valuation matches growth, but the metric is sensitive to estimates.

Growth and quality

EPS growth: Year-on-year change in earnings per share. Strong growth supports a higher valuation, but for cyclical companies it can be temporary.
Revenue growth: The growth rate of sales. It helps tell whether profits grow on real demand or mainly on cost savings.
Net margin: How much of each unit of revenue is left as net profit. A higher margin often points to stronger pricing power or more efficient operations.
ROE: Return on equity. A high ROE can signal a quality business, but check that it is not artificially boosted by heavy debt.

Most data available. Missing values mean the market data source did not provide them for this ticker. The data is indicative and may be delayed. Price as of 26/10/2026.

Management and competitive advantage

Both are estimated by the AI from the company profile, news and results. They do not count towards the 6-pillar financial health score. The AI comments are in Czech.

good

Vedení pod Kentarem Okudou získává mírně nadprůměrné hodnocení za řízení rozsáhlé mezinárodní finanční skupiny, avšak dostupné údaje neumožňují podrobně posoudit jeho exekuci ani správu společnosti.

good

Nomura těží ze zavedené značky, klientských vztahů a rozsahu v oblasti obchodování, správy majetku a investičního bankovnictví. Konkurenční výhoda je částečně omezena cykličností kapitálových trhů a silnou konkurencí.

Information

Type: Global stock
Symbol: NMR
Exchange: NYSE
Currency: USD
Sector: Financial services
: 11.3x
: 28.5B USD
: 945.6 %
: 0.64

§ Risk profile

Výnosy Nomury mohou výrazně kolísat s tržní aktivitou a výsledky obchodování. Český investor navíc nese měnové riziko jenu a dolaru vůči koruně; u amerického depozitního certifikátu mohou být relevantní také poplatky a podmínky brokera.

Ask the AI about Nomura Holdings (ADR)All signals